Table 2.
Technical endpoints and clinical outcomes.
| Reperfusion outcomes (Core Lab) | RapidPulseTM arm, ITT (N = 40) | RapidPulseTM Arm, PP (N = 35) | Control arm (N = 40) |
|---|---|---|---|
| First-pass mTICI scores — no. (%) | |||
| TICI 3 | 13 (33.3%) | 13 (37.1%) | 11 (28.2%) |
| TICI 2c | 8 (20.5%) | 8 (22.9%) | 4 (10.3%) |
| TICI 2b | 7 (17.9%) | 6 (17.1%) | 10 (25.6%) |
| TICI 0-2a | 11 (28.2%) | 8 (22.9%) | 14 (35.9%) |
| Final pass mTICI scores — no. (%) | |||
| TICI 3 | 18 (46.2%) | 18 (51.4%) | 21 (53.8%) |
| TICI 2c | 11 (28.2%) | 8 (22.9%) | 9 (23.1%) |
| TICI 2b | 8 (20.5%) | 8 (22.9%) | 9 (23.1%) |
| TICI 0-2a | 2 (5.1%) | 1 (2.9%) | 0 (0.0%) |
| Clinical outcomes | Treatment arm, ITT (N = 40) | Treatment arm, PP (N = 35) | Control arm (N = 40) |
| NIHSS score at 24h | |||
| median | 9 | 9 | 9 |
| interquartile range | 3–14 | 2–13 | 3–15 |
| Functional ındependence — no. (%) | |||
| mRS 0-2 at 90 day | 22 (61.1%) | 21 (63.6%) | 19 (52.8%) |
ITT: intent to treat.